Address	300 Third Street Cambridge Massachusetts 02142 United States
Employees	-
Website	http://www.alnylam.com
Updated	07/08/2019
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new class of innovative medicines with a core focus on RNAi therapeutics for the treatment of genetically defined diseases. The company was founded by John Kennedy Clarke, Paul R.